Yusuke Endo

ORCID: 0000-0002-9637-1951 · 6 papers in corpus
lab-animal 2025
Scientific reports ·doi:10.1038/s41598-025-13102-3

Transformation of cardiac fibroblasts into matrix-producing myofibroblasts plays an important role in tissue repair and fibrosis after myocardial injury. Tcf21 is a basic helix-loop-helix transcription factor that is essential for the devel…

other 2023
Gynecologic and obstetric investigation ·doi:10.1159/000534666

OBJECTIVES: Approximately 17-44% of women diagnosed with endometriosis have ovarian endometriomas (cysts). Although ovarian endometriomas may adversely affect quality of life and work performance, the associations among patient characterist…

2023
·doi:10.6084/m9.figshare.24547369

Objectives: Approximately 17–44% of women diagnosed with endometriosis have ovarian endometriomas (cysts). Although ovarian endometriomas may adversely affect quality of life and work performance, no reports have been published on the relat…

other 2020
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14424

AIM: Tokishakuyakusan (TSS) is representative of popular Kampo medicines for Japanese women to treat dysmenorrhea, irregular menstruation and menopause. Current hormonal treatments and low-dose oral contraceptives (OCs) used as a first-choi…

nonrandomized-trial 2017
Yonago acta medica ·doi:10.24563/yam.2017.12.003

BACKGROUND: SR-16234 is a selective estrogen receptor modulator (SERM) structurally different from approved SERM and has been reported to have estrogen receptor (ER) α antagonistic activity and strong affinity with a weak partial agonistic …

nonrandomized-trial 2017
·doi:10.33160/yam.2017.12.003

Background SR-16234 is a selective estrogen receptor modulator (SERM) structurally different from approved SERM and has been reported to have estrogen receptor (ER) α antagonistic activity and strong affinity with a weak partial agonistic a…